BACKGROUND/AIMS: The supply of docosahexaenoic acid (DHA, 22:6omega-3), important for fetal/infant neurodevelopment, depends on the maternal fatty acid (FA) status, which may be marginal in central Europe. Therefore, we investigated the effect of a daily vitamin/mineral supplement with and without 200 mg DHA from mid-pregnancy through lactation on the DHA concentrations in maternal and infant red blood cell phospholipids (RBC%), and in breast milk FA (%). METHODS:At 21 weeks' gestation, 144 women were enrolled into a randomised, double-blind clinical trial receiving daily: (1) a basic vitamin-mineral supplement (Vit/Min group), (2) Vit/Min plus 4.5 g fructo-oligosaccharide (FOS group), or (3) Vit/Min plus 4.5 g FOS plus 200 mg fish oil-derived DHA (DHA-FOS group). FAs were determined by capillary gas-liquid chromatography. RESULTS: While maternal RBC-DHA% at enrolment was not different, at 37 weeks gestation, and 3 months after delivery RBC-DHA% were significantly higher in the DHA-FOS group. The breast milk DHA% was twice as high in the DHA-FOS group (0.50%) than in the two others (0.25 %) (p < 0.001), and the ratio ARA/DHA in the DHA-FOS group was 1.0 +/- 0.43, in the others 2.1 +/- 0.43 (p < 0.001). The RBC-DHA% of the infants in the DHA-FOS group was also significantly higher, and correlated significantly with maternal RBC-DHA% before and 3 months after delivery. CONCLUSIONS: In central Europe, a dose of 200 mg/day DHA from mid-pregnancy through lactation seems appropriate to improve the DHA status of mothers and infants. 2008 S. Karger AG, Basel.
RCT Entities:
BACKGROUND/AIMS: The supply of docosahexaenoic acid (DHA, 22:6omega-3), important for fetal/infant neurodevelopment, depends on the maternal fatty acid (FA) status, which may be marginal in central Europe. Therefore, we investigated the effect of a daily vitamin/mineral supplement with and without 200 mg DHA from mid-pregnancy through lactation on the DHA concentrations in maternal and infant red blood cell phospholipids (RBC%), and in breast milk FA (%). METHODS: At 21 weeks' gestation, 144 women were enrolled into a randomised, double-blind clinical trial receiving daily: (1) a basic vitamin-mineral supplement (Vit/Min group), (2) Vit/Min plus 4.5 g fructo-oligosaccharide (FOS group), or (3) Vit/Min plus 4.5 g FOS plus 200 mg fish oil-derived DHA (DHA-FOS group). FAs were determined by capillary gas-liquid chromatography. RESULTS: While maternal RBC-DHA% at enrolment was not different, at 37 weeks gestation, and 3 months after delivery RBC-DHA% were significantly higher in the DHA-FOS group. The breast milkDHA% was twice as high in the DHA-FOS group (0.50%) than in the two others (0.25 %) (p < 0.001), and the ratio ARA/DHA in the DHA-FOS group was 1.0 +/- 0.43, in the others 2.1 +/- 0.43 (p < 0.001). The RBC-DHA% of the infants in the DHA-FOS group was also significantly higher, and correlated significantly with maternal RBC-DHA% before and 3 months after delivery. CONCLUSIONS: In central Europe, a dose of 200 mg/day DHA from mid-pregnancy through lactation seems appropriate to improve the DHA status of mothers and infants. 2008 S. Karger AG, Basel.
Authors: Cornelius M Smuts; Minzhao Huang; David Mundy; Terry Plasse; Stacey Major; Susan E Carlson Journal: Obstet Gynecol Date: 2003-03 Impact factor: 7.661
Authors: A A Welch; E Lund; P Amiano; M Dorronsoro; M Brustad; M Kumle; M Rodriguez; C Lasheras; L Janzon; J Jansson; R Luben; E A Spencer; K Overvad; A Tjønneland; F Clavel-Chapelon; J Linseisen; K Klipstein-Grobusch; V Benetou; X Zavitsanos; R Tumino; R Galasso; H B Bueno-De-Mesquita; M C Ocké; U R Charrondière; N Slimani Journal: Public Health Nutr Date: 2002-12 Impact factor: 4.022
Authors: J A Dunstan; T A Mori; A Barden; L J Beilin; P G Holt; P C Calder; A L Taylor; S L Prescott Journal: Eur J Clin Nutr Date: 2004-03 Impact factor: 4.016
Authors: Anna M Pauter; Sofia Trattner; Amanda Gonzalez-Bengtsson; Emanuela Talamonti; Abolfazl Asadi; Olga Dethlefsen; Anders Jacobsson Journal: J Lipid Res Date: 2016-11-18 Impact factor: 5.922
Authors: Lu-Te Chuang; Robert H Glew; Chia-Chun Li; Dorothy J VanderJagt; Julie S Broyles; Gretchen M Ray; Vallabh O Shah Journal: J Diabetes Mellitus Date: 2012-11